Please wait...

Canadian Pharmacists Association
Canadian Pharmacists Association
Facebook Share
Twitter Share
LinkedIn Share
Google Plus Share
Email Share

CPhA Committees & Working Groups

In an effort to incorporate regional perspectives and draw on expertise from pharmacists and other members of the health care community from across the country, CPhA has formed a range of committees and working groups.  The following committees and working groups help to inform CPhA’s policies and positions and guide its activities.

Active Committees

Advocacy Committee

The Advocacy Committee is a Standing Committee of CPhA’s Board of Directors responsible for developing the organization’s advocacy agenda. The Committee works to develop CPhA’s national policies, policy frameworks and criteria for engaging others to enhance CPhA membership interests in the area of advocacy and government relations on behalf of the profession of pharmacy.


  • Jim Armour (Chair)
  • Allison Bodnar, CEO, Pharmacy Association of Nova Scotia
  • Annette Robinson, CPhA Board Representative
  • Dawn Martin, Executive Director, Pharmacy Association of Saskatchewan
  • Doug Thidrickson, CPhA Board Representative
  • Perry Martin, Vice-President, Government Relations, Loblaw
  • Shawn Bugden, Association of Faculties of Pharmacy of Canada
  • Stephanie Tweel, CPhA Board Representative
  • Christina Tulk, CPhA Chair*
  • Glen Doucet, CPhA CEO*


CPhA-AFPC Pharmacy Workforce Planning Committee

The CPhA-AFPC Pharmacy Workforce Planning Committee was convened in July 2016 to conduct a comprehensive assessment of the current and future pharmacist workforce, focusing on both the supply and demand for pharmacists. Membership is pan-Canadian, and includes representation from across the pharmacy community (including professional associations, regulators, educators, and accreditors).


  • Canadian Pharmacists Association (CPhA)
  • Association of Faculties of Pharmacy of Canada (AFPC)
  • Association des pharmaciens des établissements de santé du Québec (APES)
  • Canadian Association of Pharmacy Students and Interns (CAPSI)
  • Canadian Association of Pharmacy Technicians (CAPT)
  • Canadian Council for the Accreditation of Pharmacy Programs (CCAPP)
  • Canadian Council on Continuing Education in Pharmacy (CCCEP)
  • Canadian Pharmacy Technicians Educators Association (CPTEA)
  • Canadian Society of Hospital Pharmacists (CSHP)
  • National Association of Pharmacy Regulatory Authorities (NAPRA)
  • Neighbourhood Pharmacy Association of Canada (NPAC)
  • Pharmacy Examining Board of Canada (PEBC)
  • Provincial pharmacy regulatory organizations
  • Provincial pharmacy associations

Canadian Pharmacists’ Harmonized Scope (CPHS) 2020

The Canadian Pharmacists’ Harmonized Scope (CPHS) 2020 initiative was launched in 2017 to define, describe and develop a national, forward-looking harmonized scope of practice for pharmacists across Canada. This initiative is guided by a CPHS 2020 Steering Committee, with project-specific working groups being convened as required. Visit the CPHS 2020 web page for details on the Steering Committee and working groups associated with this initiative.

Drug Supply Working Group

The Drug Supply Working Group will help inform and refine CPhA’s advocacy goals, activities and recommendations regarding the safety and supply of Canada’s drug supply.


  • Dean Miller, Whole Health Pharmacy Partners
  • Deb Saltmarche, Shoppers Drug Mart
  • Farouk Haji, Alberta Pharmacists’ Association
  • Geneviève Pelletier, Association québécoise des pharmaciens propriétaires
  • Jake Reid, New Brunswick Pharmacists’ Association
  • Joseph Hanna, Costco
  • Lawrence Varga, Costco
  • Mina Tadrous, Women’s College Hospital
  • Sherif Guorgui, OnPharm United
  • Smita Patil, McKesson

Knowledge to Practice Advisory Circle (KPAC)

The purpose of KPAC is to support and advise CPhA staff in the development and implementation of knowledge translation plans, activities and services, in alignment with the organization’s mission to advance the health and well-being of Canadians through excellence in pharmacist care.


  • Carla Beaton, Medical Pharmacies Group Limited
  • Caroline Sirois, Laval University
  • Drew Peddie, Shoppers Drug Mart
  • Emily Black, Dalhousie University
  • Jaris Swidrovich, University of Saskatchewan
  • Kit Poon, Alberta Pharmacists Association
  • Lisa McCarthy, Women’s College Hospital & University of Toronto
  • Prev Naidoo, Yukon Hospital Corporation
  • Robert Pammett, University of British Columbia
  • Shawn Bugden, Memorial University of Newfoundland
  • Shelita Dattani, CPhA
  • Sherilyn Houle, University of Waterloo
  • Sonal Purohit, University of Manitoba
  • Zack Dumont, Saskatchewan Health Authority

Public Health Working Group
This working group provides guidance to CPhA on the elements of consensus framework for an enhanced role for pharmacists in public health.


  • Angeline Ng, Ontario Pharmacists Association
  • Ashley Lian, McKesson
  • Bryce Wong, British Columbia Pharmacy Association
  • Deb Saltmarche, Shoppers Drug Mart
  • Geneviève Pelletier, Association québécoise des pharmaciens propriétaires
  • Melanie Cann, PharmaChoice
  • Myla Bulych, Pharmacy Association of Saskatchewan
  • Matt Tachuk, Alberta Pharmacists’ Association
  • Nancy Waite, University of Waterloo
  • Heather Mohr, CPhA
  • Shelita Dattani, CPhA
  • Joelle Walker, CPhA

Third-Party Payer Working Group

The Third-Party Payer Working Group assists CPhA in supporting its mission and Organizational Members on issues related to pharmacists’ relationships with public and private payers. The Working Group identifies issues with public and private payer policies, processes and procedures that impact pharmacists’ ability to deliver quality care to their patients, develops consensus and communications, and identifies strategies to address these issues and improve working relationships with third-party payers.


  • Allan Malek, Ontario Pharmacists Association
  • Allison Bodnar, Pharmacy Association of Nova Scotia
  • Brenna Shearer, Pharmacists Manitoba
  • Bryce Wong, British Columbia Pharmacy Association
  • Erin MacKenzie, Prince Edward Island Pharmacists Association
  • Geneviève Pelletier, Association québécoise des pharmaciens propriétaires
  • Janet MacDonnell, New Brunswick Pharmacists’ Association
  • Jennifer Collingwood, Pharmacists’ Association of Newfoundland and Labrador
  • Krystal Wynnyk, Alberta Pharmacists’ Association
  • Myla Wollbaum, Pharmacy Association of Saskatchewan

Inactive Committees

In addition to active committees and working groups, several now disbanded groups were formed to carry out consultations for specific policy initiatives.

Professional Practice Working Group

The Professional Practice Working Group is tasked with defining and developing a forward-thinking, uniformed national scope of practice for the pharmacy profession in Canada. The Group will also help identify practice and economic research required to support its vision for a harmonized national scope of practice.

National Pharmacy Continuing Professional Development (CPD) Working Group

The National CPD Working Group facilitates engagement, coordination and consultation between CPhA and its Organizational Members on CPD for pharmacists. The Working Group also monitors CPD availability, needs and gaps; and advises CPhA and its Organizational Members on appropriate development and delivery of CPD programs.

CPPRG Executive Committee

The aim of the Canadian Pharmacy Practice Research Group (CPPRG) is to provide leadership in the generation, dissemination and application of practice-based research evidence to optimize the role of pharmacists in medication management and improved patient outcomes. This committee has been replaced with the KPAC.

Opioid Working Group

The Opioid Working Group was formed in October 2016 to inform CPhA’s commitments to the government-led Joint Statement of Action to Address the Opioid Crisis. The Working Group made recommendations in the areas of information technology to support responsible prescribing, collaborative approaches addressing prescription opioid misuse, and regulatory change to leverage the role of pharmacists. The group also played an advisory role in the preparation and planning for CPhA’s Opioid Summit in June 2017.

Pay for Performance Working Group

The Pay for Performance Working Group explores the need for pharmacy-led pay for performance type approaches, taking into consideration the current pharmacy legal and regulatory framework in Canada as well as public and private payor considerations. The Working Group also provides strategic leadership in identifying possible Canadian pharmacy-led solutions to metrics-based pharmacy rating systems.

Pharmacare Principles & Priorities Advisory Panel

The Pharmacare Principles & Priorities Advisory Panel was formed in Spring 2015 to advise on the creation of CPhA’s Pharmacare 2.0 Principles & Priorities. The Committee was disbanded following the document’s release in September 2015.

Pharmacare Consensus Working Group

The Pharmacare Consensus Working Group is a collaboration between the Canadian Pharmacists Association, the Best Medicines Coalition, and the Health Care Charities Coalition of Canada. The Working Group was formed in 2016 to build consensus around the core components, principles and priorities of a pan-Canadian pharmaceutical care strategy that reflects the needs of patients and supports health providers in delivering the best possible care.

Medical Marijuana Policy Working Group

The Medical Marijuana Working Group was formed in Summer 2015 to review CPhA’s policy on medical marijuana and advise on a KPMG report. The Group was disbanded following approval of CPhA’s new policy in March 2016.

Assisted Dying Working Group

The Assisted Dying Policy Working Group was an ad hoc working group formed in September 2015 to create CPhA policy on pharmacist involvement in medical assistance in dying. The Group oversaw a national survey of 1000+ individual pharmacists and advised on CPhA’s submissions to both Liberal and Conservative governments. The Group was disbanded in February 2016 following public release of CPhA’s policy position.

External Committees & Working Groups

In addition to CPhA-led committees, the Association is also a member of several external groups.

Pharmacy and Health Insurance Steering Coalition (PHISC)

PHISC is a forum to facilitate ongoing discussion between senior representatives of private sector insurers and pharmacy. PHISC identifies common areas of interest to leverage the role of pharmacists in benefit plan management to achieve positive health outcomes for plan members/patients and cost management goals for plan sponsors, identifies opportunities for collaboration to reduce costs of administration of third party plans for pharmacy providers and private payers administrators, and enhances customer service to plan members/patients, plan sponsors, and pharmacists.

AMS Canada Steering Committee

CPhA is committed to highlighting the vital role pharmacists play in antimicrobial stewardship and is participating in an AMS Canada Steering Committee; a national multi-stakeholder, multi-sector group led by the National Collaborating Centre for Infectious Diseases (NCCID) and HealthCareCAN. The mandate of this Committee is to further develop, scale and spread antimicrobial stewardship best practices across all sectors to battle the global public health problem of antimicrobial resistance.

Organizations for Health Action (HEAL)

HEAL is a coalition of national health associations and organizations dedicated to protecting and strengthening Canada’s health system. HEAL meets 4 times per year with the objectives of sharing information across organizations, working on those strategic issues that are of importance to all members, and meeting with external organizations to discuss policy issues of mutual interest and importance.